tiprankstipranks
Advertisement
Advertisement

ASMB Stock Latest News

ASMB Earnings this Week: How Will it Perform?
Pre-EarningsASMB Earnings this Week: How Will it Perform?
8h ago
ASMB
Assembly Biosciences price target raised to $43 from $39 at Guggenheim
PremiumThe Fly
Assembly Biosciences price target raised to $43 from $39 at Guggenheim
29d ago
ASMB
GILD
Assembly Biosciences Adopts 2026 Performance-Based Bonus Plan
PremiumCompany Announcements
Assembly Biosciences Adopts 2026 Performance-Based Bonus Plan
1M ago
8K
ASMB
Assembly Biosciences Advances HSV-2 Drug ABI-1179 With Completion of Early-Stage Trial
PremiumCompany Announcements
Assembly Biosciences Advances HSV-2 Drug ABI-1179 With Completion of Early-Stage Trial
1M ago
ASMB
Assembly Biosciences files $400M mixed securities shelf
PremiumThe Fly
Assembly Biosciences files $400M mixed securities shelf
2M ago
ASMB
Is ASMB a Buy, Before Earnings?
PremiumPre-EarningsIs ASMB a Buy, Before Earnings?
2M ago
ASMB
Gilead Partnership and Positive HSV Data De‑Risk Assembly Biosciences, Supporting Buy Rating and $50 Price Target
Premium
Ratings
Gilead Partnership and Positive HSV Data De‑Risk Assembly Biosciences, Supporting Buy Rating and $50 Price Target
4M ago
ASMB
Gilead opt-in ‘significantly de-risks’ Assembly pipeline, says H.C. Wainwright
Premium
The Fly
Gilead opt-in ‘significantly de-risks’ Assembly pipeline, says H.C. Wainwright
4M ago
ASMB
GILD
Gilead exercises option to license Assembly helicase-primase inhibitor programs
PremiumThe Fly
Gilead exercises option to license Assembly helicase-primase inhibitor programs
4M ago
ASMB
GILD
Assembly Biosciences Completes Key Phase 1a Study on ABI-6250
PremiumCompany Announcements
Assembly Biosciences Completes Key Phase 1a Study on ABI-6250
5M ago
ASMB
Positive Buy Rating for Assembly Biosciences Driven by Promising HSV-2 Program and Strategic Partnerships
PremiumRatings
Positive Buy Rating for Assembly Biosciences Driven by Promising HSV-2 Program and Strategic Partnerships
5M ago
ASMB
Assembly Biosciences Reports Positive Phase 1b Results
PremiumCompany Announcements
Assembly Biosciences Reports Positive Phase 1b Results
5M ago
8K
ASMB
Assembly Biosciences announces interim results from ABI-1179, ABI-5366 trials
PremiumThe FlyAssembly Biosciences announces interim results from ABI-1179, ABI-5366 trials
5M ago
ASMB
GILD
Assembly Biosciences price target raised to $40 from $29 at Mizuho
Premium
The Fly
Assembly Biosciences price target raised to $40 from $29 at Mizuho
6M ago
ASMB
Assembly Biosciences: Strong Clinical Execution and Strategic Partnerships Drive Buy Rating
Premium
Ratings
Assembly Biosciences: Strong Clinical Execution and Strategic Partnerships Drive Buy Rating
6M ago
ASMB
Assembly Biosciences Inc. Reports Q3 2025 Earnings
PremiumCompany Announcements
Assembly Biosciences Inc. Reports Q3 2025 Earnings
6M ago
ASMB
Assembly Biosciences reports Q3 EPS (72c), consensus (65c)
PremiumThe Fly
Assembly Biosciences reports Q3 EPS (72c), consensus (65c)
6M ago
ASMB
Assembly Biosciences announces Phase 1b data for ABI-4334
PremiumThe Fly
Assembly Biosciences announces Phase 1b data for ABI-4334
6M ago
ASMB
ASMB Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ASMB Earnings this Week: How Will it Perform?
6M ago
ASMB
Assembly Biosciences Advances HSV-2 Treatment Study with ABI-1179
PremiumCompany AnnouncementsAssembly Biosciences Advances HSV-2 Treatment Study with ABI-1179
6M ago
ASMB
Assembly Biosciences’ Promising HSV-2 Treatment Study: Key Insights for Investors
Premium
Company Announcements
Assembly Biosciences’ Promising HSV-2 Treatment Study: Key Insights for Investors
6M ago
ASMB
Assembly Biosciences’ ABI-6250 Study: A Potential Game-Changer in Hepatitis Treatment
Premium
Company Announcements
Assembly Biosciences’ ABI-6250 Study: A Potential Game-Changer in Hepatitis Treatment
6M ago
ASMB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >